Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $861 | $0 | $0 | $5,277 |
| - Cash | $217 | $171 | $189 | $278 |
| + Debt | $227 | $204 | $163 | $267 |
| Enterprise Value | $871 | $34 | -$25 | $5,267 |
| Revenue | $1,400 | $1,053 | $1,233 | $1,266 |
| % Growth | 32.9% | -14.6% | -2.6% | – |
| Gross Profit | $753 | $551 | $771 | $806 |
| % Margin | 53.8% | 52.4% | 62.5% | 63.7% |
| EBITDA | $260 | $192 | $229 | $2,125 |
| % Margin | 18.5% | 18.2% | 18.6% | 167.9% |
| Net Income | $93 | $17 | $51 | $1,987 |
| % Margin | 6.7% | 1.6% | 4.2% | 156.9% |
| EPS Diluted | 0.16 | 0.028 | 0.087 | 3.37 |
| % Growth | 463.4% | -67.4% | -97.4% | – |
| Operating Cash Flow | $242 | $110 | $284 | $211 |
| Capital Expenditures | -$208 | -$160 | -$214 | -$371 |
| Free Cash Flow | $34 | -$46 | $70 | -$160 |